首页 > 市场调查报告书 > 通讯

IoT 数位孪生

市场调查报告书

商品编码

1496127

医疗数位孪生市场：现况分析与预测（2024-2032）

Digital Twin in Healthcare Market: Current Analysis and Forecast (2024-2032)

出版日期: 2024年05月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 135 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

由于企业投资增加，预计医疗数位孪生市场在预测期内将以 28.9% 的复合年增长率强劲增长。由于医疗数位孪生市场具有改变病患照护、营运效率和节省成本的潜力，对医疗保健数位孪生市场的投资正在增加。最近对医疗保健数位孪生技术的投资包括：

Siemens Healthineers：2022 年，Siemens Healthineers 宣布对医疗保健数位孪生技术进行重大投资，旨在透过虚拟建模和模拟增强医学成像、诊断和患者护理。

GE医疗保健：GE医疗保健正在投资医疗保健数位孪生解决方案，重点关注医疗设备的预测性维护和医院工作流程的最佳化。据报道，到 2023 年，最近的投资将扩大医疗保健行业的数位孪生产品。

依类型划分，市场分为流程/系统数位孪生和产品数位孪生。到 2023 年，流程系统的数位孪生领域将占据主导市场占有率。医疗保健流程系统的数位孪生主要由旨在提高营运效率、降低成本和改善患者治疗效果的几个关键因素所驱动。关键驱动因素之一是医疗机构内部需要有效率的资产和流程管理。数位孪生允许医疗保健提供者对其营运进行准确的模拟，从而实现更好的资源分配、维护计划和医疗保健资产的整体管理。

根据应用，市场分为资产和流程管理、个人化医疗、药物发现等。药物发现领域预计将在一段时间内以高复合年增长率成长。医疗数位孪生市场的药物发现领域受到几个引人注目的因素的推动，这些因素旨在改变药物的开发和推向市场的方式。一个关键的驱动因素是有可能大幅减少与新药研发相关的时间和成本。数位孪生可以在模拟人体生理学中对药物交互作用进行虚拟测试，从而减少大量物理测试的需要。

依最终使用者划分，市场分为医院/诊所、临床研究机构等。到2023年，医院和诊所将占据压倒性的市场占有率。此细分市场将数位孪生用于多种目的，包括设施管理、病患流程优化和医疗设备管理。透过模拟医院运作和病患互动，医院可以优化资源分配并改善病患治疗效果。

为了更瞭解数位孪生在医疗保健产业的市场实施情况，市场为北美（美国、加拿大等北美地区）、欧洲（德国、英国、法国、西班牙、义大利等）欧洲地区）和亚洲，根据太平洋地区（中国、日本、印度和其他亚太地区）和其他地区的全球分布进行分析。亚太地区预计将在一段时间内以较高的复合年增长率成长。推动亚太医疗保健数位孪生市场成长的驱动力有很多。首先，人工智慧、物联网和云端运算等技术的快速进步正在推动针对医疗保健产业的复杂数位孪生解决方案的开发。这些创新实现了即时监控、预测分析和个人化医疗保健服务，推动了该地区医疗保健提供者采用数位双胞胎。此外，不断上涨的医疗保健成本以及对基于价值的护理和以患者为中心的方法的日益重视将推动对数位医疗解决方案（包括数位孪生）的投资，以改善临床结果和营运效率。

市场的主要营运公司包括 Atos SE、Koninklijke Philips N.V.、Altair Engineering Inc.、Verto Health、Twin Health、Dassault Systemes、PrediSurge、Virtonomy GmbH、Siemens Healthineers AG 和 Microsoft。

In recent years, the concept of digital twins has emerged as a transformative force across various industries, including healthcare. Rooted in simulation, data analytics, and IoT (Internet of Things), digital twins offer a virtual replica or representation of physical entities, be it a machine, a process, or, in the case of healthcare, a patient. This paradigm shift in healthcare leverages advanced technologies to create a comprehensive digital counterpart of an individual's health profile, encompassing physiological parameters, medical history, genetic makeup, and lifestyle factors. By integrating real-time data streams from wearable devices, medical sensors, electronic health records (EHRs), and other sources, digital twins enable healthcare providers to monitor, analyze, and predict health outcomes with unprecedented accuracy and granularity. As healthcare systems strive to embrace innovation and harness the power of digital transformation, digital twins stand poised to redefine the landscape of healthcare delivery, ushering in an era of precision medicine and proactive wellness management.

The Digital Twin in Healthcare Market is expected to grow at a strong CAGR of 28.9% during the forecast period owing to increasing investment by companies. The growing investment in digital twins within the healthcare market is driven by the potential for transformative impact on patient care, operational efficiency, and cost reduction. Recent investments in digital twin technology in healthcare include:

Siemens Healthineers: In 2022, Siemens Healthineers announced significant investments in digital twin technology for healthcare applications, aiming to enhance medical imaging, diagnostics, and patient care through virtual modeling and simulation.

GE Healthcare: GE Healthcare has been investing in digital twin solutions for healthcare, focusing on predictive maintenance for medical equipment and optimizing hospital workflows. Recent investments were reported in 2023 to expand their digital twin offerings in the healthcare sector.

Based on types, the market is bifurcated into process & system digital twin, and product digital twin. The process & system digital twin segment held the dominant share of the market in 2023. The process and system digital twins in healthcare are primarily driven by several key factors that aim to enhance operational efficiency, reduce costs, and improve patient outcomes. One major driving factor is the need for efficient asset and process management within healthcare facilities. Digital twins enable healthcare providers to create accurate simulations of their operations, allowing for better resource allocation, maintenance scheduling, and overall management of medical assets.

By application, the market is segmented into asset and process management, personalized medicine, drug discovery, and others. The drug discovery segment is anticipated to grow with a high CAGR during the forthcoming period. The drug discovery segment in the digital twin market in healthcare is propelled by several compelling factors that aim to revolutionize how pharmaceuticals are developed and brought to market. A primary driver is the potential for significant reductions in time and cost associated with the R&D of new drugs. Digital twins allow for the virtual testing of drug interactions within simulated human physiology, reducing the need for extensive physical trials.

Based on end users, the market is segmented into hospitals and clinics, clinical research organizations, and others. The hospitals and clinics held the dominant share of the market in 2023. This segment uses digital twins for various purposes including facility management, patient flow optimization, and medical equipment management. By simulating hospital operations and patient interactions, hospitals can optimize resource allocation and improve patient outcomes.

For a better understanding of the market adoption of the digital twin in the healthcare industry, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Asia Pacific is anticipated to grow with a high CAGR during the forthcoming period. Several driving factors are propelling the growth of the Asia Pacific digital twin in the healthcare market. Firstly, rapid technological advancements, such as AI, IoT, and cloud computing, are fostering the development of sophisticated digital twin solutions tailored to the healthcare sector. These innovations enable real-time monitoring, predictive analytics, and personalized healthcare delivery, driving the adoption of digital twins among healthcare providers in the region. Moreover, increasing healthcare expenditure and a growing emphasis on value-based care and patient-centric approaches incentivize investments in digital health solutions, including digital twins, to improve clinical outcomes and operational efficiency. Additionally, government initiatives promoting healthcare digitization, such as the National Digital Health Mission in India launched in 2020, are driving awareness and adoption of digital health technologies, including digital twins, among healthcare stakeholders in the Asia Pacific region.

Some of the major players operating in the market include Atos SE; Koninklijke Philips N.V.; Altair Engineering Inc.; Verto Health; Twin Health; Dassault Systemes; PrediSurge; Virtonomy GmbH; Siemens Healthineers AG'; and Microsoft.

1.MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Digital Twin In Healthcare Market
2.2. Research Methodology of the Digital Twin In Healthcare Market
2.3. Respondent Profile

3.EXECUTIVE SUMMARY

3.1. Industry Synopsis
3.2. Segmental Outlook
- 3.2.1. Market Growth Intensity
3.3. Regional Outlook

4.MARKET DYNAMICS

4.1. Drivers
4.2. Opportunity
4.3. Restraints
4.4. Trends
4.5. PESTEL Analysis
4.6. Demand Side Analysis
4.7. Supply Side Analysis
- 4.7.1. Merger & Acquisition
- 4.7.2. Investment Scenario
- 4.7.3. Industry Insights: Leading Startups and Their Unique Strategies

5.PRICING ANALYSIS

5.1. Regional Pricing Analysis
5.2. Price Influencing Factors

6.GLOBAL DIGITAL TWIN IN HEALTHCARE MARKET REVENUE (USD BN), 2022-2032F

7.MARKET INSIGHTS BY TYPE

7.1. Process & System Digital Twin
7.2. Product Digital Twin

8.MARKET INSIGHTS BY APPLICATION

8.1. Asset and Process Management
8.2. Personalized Medicine
8.3. Drug Discovery
8.4. Others

9.MARKET INSIGHTS BY END USER

9.1. Hospital and Clinics
9.2. Clinical Research Organizations
9.3. Others

10.MARKET INSIGHTS BY REGION

10.1. North America
- 10.1.1. U.S.
- 10.1.2. Canada
- 10.1.3. Rest of North America
10.2. Europe
- 10.2.1. Germany
- 10.2.2. U.K.
- 10.2.3. France
- 10.2.4. Italy
- 10.2.5. Spain
- 10.2.6. Rest of Europe
10.3. Asia-Pacific
- 10.3.1. China
- 10.3.2. Japan
- 10.3.3. India
- 10.3.4. Rest of Asia-Pacific
10.4. Rest of World

11.VALUE CHAIN ANALYSIS

11.1. Marginal Analysis
11.2. List of Market Participants

12.COMPETITIVE LANDSCAPE

12.1. Competition Dashboard
12.2. Competitor Market Positioning Analysis
12.3. Porter Five Force Analysis

13.COMPANY PROFILED

13.1. Atos SE
- 13.1.1. Company Overview
- 13.1.2. Key Financials
- 13.1.3. SWOT Analysis
- 13.1.4. Product Portfolio
- 13.1.5. Recent Developments
13.2. Koninklijke Philips N.V.
13.3. Altair Engineering Inc.
13.4. Verto Health
13.5. Twin Health
13.6. Dassault Systemes
13.7. PrediSurge
13.8. Virtonomy GmbH
13.9. Siemens Healthineers AG'
13.10. Microsoft